Addex Therapeutics Ltd (ADXN) — Cash Flow-to-Debt Ratio
Addex Therapeutics Ltd (ADXN) has a Cash Flow-to-Debt Ratio of -0.39x as of September 2025, meaning its operating cash flow of $-533.20K could theoretically repay 0% of its total liabilities ($1.37 Million) in one year. See how much free cash does Addex Therapeutics Ltd generate to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Addex Therapeutics Ltd Cash Flow-to-Debt Ratio (2006–2024)
Historical debt coverage capacity for Addex Therapeutics Ltd across 19 annual periods. Also explore Addex Therapeutics Ltd (ADXN) net asset momentum to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Addex Therapeutics Ltd (2006–2024)
Year-by-year debt coverage analysis for Addex Therapeutics Ltd. For market capitalisation and broader financial context, see ADXN market cap.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | -5.37x | $-5.37 Million | $1.00 Million | ▼ -134.8% |
| 2023 | -2.29x | $-7.99 Million | $3.50 Million | ▲ +53.1% |
| 2022 | -4.88x | $-16.44 Million | $3.37 Million | ▼ -86.1% |
| 2021 | -2.62x | $-14.71 Million | $5.61 Million | ▼ -19.9% |
| 2020 | -2.19x | $-12.18 Million | $5.57 Million | ▼ -73.0% |
| 2019 | -1.26x | $-9.48 Million | $7.50 Million | ▼ -314.4% |
| 2018 | 0.59x | $1.75 Million | $2.97 Million | ▲ +147.5% |
| 2017 | -1.24x | $-2.13 Million | $1.72 Million | ▲ +32.6% |
| 2016 | -1.84x | $-2.69 Million | $1.46 Million | ▲ +14.2% |
| 2015 | -2.14x | $-2.63 Million | $1.23 Million | ▼ -97.1% |
| 2014 | -1.09x | $-1.80 Million | $1.65 Million | ▲ +80.3% |
| 2013 | -5.53x | $-15.78 Million | $2.85 Million | ▼ -2.2% |
| 2012 | -5.41x | $-29.45 Million | $5.44 Million | ▼ -99.3% |
| 2011 | -2.71x | $-26.55 Million | $9.78 Million | ▲ +14.5% |
| 2010 | -3.18x | $-31.34 Million | $9.87 Million | ▲ +11.5% |
| 2009 | -3.59x | $-39.38 Million | $10.97 Million | ▼ -169.0% |
| 2008 | -1.33x | $-17.79 Million | $13.34 Million | ▲ +62.5% |
| 2007 | -3.56x | $-33.00 Million | $9.27 Million | ▲ +25.8% |
| 2006 | -4.80x | $-19.56 Million | $4.07 Million | — |